A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT06087406 · TERMINATED
Trial details
- NCT number
- NCT06087406
- Sponsor
- IGM Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2025-02-10
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.